1. Gossen, M., Bonin, A. & Bujard, H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements.Trends Biol. Sci.18, 471–475 (1993).

   Article CAS  Google Scholar 

2. Spencer, D.M. Creating conditional mutants in mammals.Trends Genet.12, 181–187 (1996).

   Article CAS  Google Scholar 

3. Ptashne, M. How eukaryotic transcriptional activators work.Nature335, 683–689 (1988).

   Article CAS  Google Scholar 

4. Brent, R. & Ptashne, M. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor.Cell43, 729–736 (1985).

   Article CAS  Google Scholar 

5. Hope, I.A. & Struhl, K. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast.Cell46, 885–894 (1986).

   Article CAS  Google Scholar 

6. Fields, S. & Song, O.-K. A novel genetic system to detect protein-protein interactions.Nature340, 245–246 (1989).

   Article CAS  Google Scholar 

7. Spencer, D.M., Wandless, T.J., Schreiber, S.L. & Crabtree, G.R. Controlling signal transduction with synthetic ligands.Science262, 1019–1024 (1993).

   Article CAS  Google Scholar 

8. Austin, D.J., Crabtree, G.R. & Schreiber, S.L. Proximity versus allostery: The role of regulated protein dimerization in biology.Chem. Biol.1, 131–136 (1994).

   Article CAS  Google Scholar 

9. Pruschy, M.N.et a Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012.Chem. Biol.1, 163–172 (1994).

   Article CAS  Google Scholar 

10. Spencer, D.M., Graef, I., Austin, D.J., Schreiber, S.L. & Crabtree, G.R. A general strategy for producing conditional alleles of Src-like tyrosine kinases.Proc. Natl. Acad. Sci. USA92, 9805–9809 (1995).

    Article CAS  Google Scholar 

11. Holsinger, L.J., Spencer, D.M., Austin, D.J., Schreiber, S.L. & Crabtree, G.R. Signal transduction in T lymphocytes using a conditional allele of Sos.Proc. Natl Acad. Sci. USA92, 9810–9814 (1995).

    Article CAS  Google Scholar 

12. Belshaw, P.J., Ho, S.N., Crabtree, G.R. & Schreiber, S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces het-erodimerization of proteins.Proc. Natl. Acad. Sci. USA93, 4604–4607 (1996).

    Article CAS  Google Scholar 

13. Ho, S.N., Biggar, S.R., Spencer, D.M., Schreiber, S.L. & Crabtree, G.R. Controlling transcription with synthetic ligands.Nature (in the press).

14. Bierer, B.E.et al. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proc. Natl. Acad. Sci. USA87, 9231–9235 (1990).

    Article CAS  Google Scholar 

15. Brown, E.J.et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.Nature369, 756–758 (1994).

    Article CAS  Google Scholar 

16. Chiu, M.L., Katz, H. & Berlin, V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.Proc. Natl. Acad. Sci. USA91, 12574–12578 (1994).

    Article CAS  Google Scholar 

17. Sabatini, D.M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S.H. RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.Cell78, 35–43 (1994).

    Article CAS  Google Scholar 

18. Sabers, C.J.et al. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.J. Biol. Chem.270, 815–822 (1995).

    Article CAS  Google Scholar 

19. Stan, R.et al. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.J. Biol. Chem.269, 32037–32030 (1994).

    Google Scholar 

20. Kahan, B., Chang, J. & Sehgal, S. Preclinical evaluation of a new potent im-munosuppressive agent, rapamycin.Transplantation52, 185–191 (1991).

    Article CAS  Google Scholar 

21. Kay, J., Kromwel, L., Doe, S. & Denyer, M. Inhibition of T and B lymphocyte proliferation by rapamycin.Immunology72, 544–549 (1991).

    CAS PubMed PubMed Central  Google Scholar 

22. Stepkowski, S., Chen, H., Daloze, P. & Kahan, B., mycin, apotent immuno-suppressive drug for vascularized heart, kidney, and small bowel transplantation ir- the rat.Transplantation51, 22–26 (1991).

    Article CAS  Google Scholar 

23. Pomerantz, J.L., Sharp, P.A. & CO.Structure-based design of transcription factors.Science267, 93–96 (1995).

    Article CAS  Google Scholar 

24. Schmitz, M.L. & Baeurle, P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-KB.EMBO J.10, 3805–3817 (1991).

    Article CAS  Google Scholar 

25. Chen, J., Zheng, X.F., Brown, E.J. & Schreiber, S.L. Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue.Proc. Natl. Acad. Sci. USA92, 4947–4951 (1995).

    Article CAS  Google Scholar 

26. Heartlein, M.W.et al. Long-term production and delivery of human growth hormone.Proc. Natl. Acad. Sci. USA91, 10967–10971 (1994).

    Article CAS  Google Scholar 

27. Riddell, S.R.et al. T-cell mediated rejection of gene-modified HIV-specific cyto-toxic T lymphocytes in HIV-infected patients.Nature Med.2, 216–223 (1996).

    Article CAS  Google Scholar 

28. Stern, L.J. & Wiley, D.C. Antigenic peptide binding by class I and class II histo-compatibility proteins.Structure2, 245–251 (1994).

    Article CAS  Google Scholar 

29. Luengo, J.I.et al. Structure-activity studies of rapamycin analogs: Evidence that the C-7 methoxy is part of the effector domain and positioned at the FKBP12/FRAP interface.Chem. Biol2, 471–481 (1995).

    Article CAS  Google Scholar 

30. Belshaw, P.J., Schoepfer, J., Liu, K., Morrison, K. & Schreiber, S.L. Rational design of orthogonal receptor-ligand combinations.Angew. Chem. Int. Ed. Eng.34, 2129–2132 (1995).

    Article CAS  Google Scholar 

31. Choi, J., Chen, J., Schreiber, S.L. & Clardy, J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.Science273, 239–242 (1996).

    Article CAS  Google Scholar 

32. Attar, R.M. & Gilman, M.Z. Expression cloning of a novel zinc-finger protein that binds to the c-fos serum response element.Mol. Cell. Biol.12, 2432–2443 (1992).

    Article CAS  Google Scholar 

33. Standaert, R.F., Galat, A., Verdine, G.L. & Schreiber, S.L. Molecular cloning and overexpression of the human FK506-binding protein FKBP.Nature346, 671–674 (1990).

    Article CAS  Google Scholar 

34. Boshart, M.et al A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.Cell41, 521–530 (1985).

    Article CAS  Google Scholar 

35. Siebenlist, U.et al Promoter region of interleukin-2 gene undergoes chro-matin structure changes and confers inducibility on chloramphenicol acetyl-transferase gene during activation of T cells.Mol. Cell Biol6, 3042–3049 (1986).

    Article CAS  Google Scholar 

36. Selden, R.F., Burke-Howie, K., Rowe, M.E., Goodman, H.M. & Moore, D.D. Human growth hormone as a reporter gene in regulation studies employing transient gene expression.Mol Cell Biol.6, 3173–3179 (1986).

    Article CAS  Google Scholar 

37. Morgenstern, J.P. & Land, H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.Nucleic Acids Res.18, 3587–3596 (1990).

    Article CAS  Google Scholar 

38. Muller, A.J.et al. BCR first exon sequences specifically activate BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.Mol Cell Biol11, 1785–1792 (1991).

    Article CAS  Google Scholar 

39. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection.Proc. Natl. Acad. Sci. USA90, 8392–8396 (1993).

    Article CAS  Google Scholar 

Download references